BAMM — Body and Mind Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual income statement for Body and Mind, fiscal year end - July 31st, USD millions except per share, conversion factor applied.
2019 July 31st | 2020 July 31st | C2021 July 31st | R2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.61 | 5.29 | 26.9 | 23.4 | 22.8 |
Cost of Revenue | |||||
Gross Profit | 1.78 | 1.51 | 12 | 7.45 | 5.78 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.9 | 11.2 | 26.7 | 48.9 | 39.9 |
Operating Profit | -4.29 | -5.88 | 0.162 | -25.5 | -17 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.75 | -4.46 | 0.19 | -26.6 | -18.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.75 | -4.6 | -1.98 | -28.4 | -20.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.75 | -4.34 | -2.26 | -28.7 | -21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.75 | -4.34 | -2.26 | -28.7 | -21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.051 | -0.04 | -0.018 | -0.136 | -0.109 |